• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Mixed chimera status in patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation ; evaluation by flow cytometric analysis of intracellular WAS protein expression.

Research Project

Project/Area Number 13670776
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionHOKKAIDO UNIVERSITY

Principal Investigator

ARIGA Tadashi  Hokkaido Univ. Grad. School of Med., Corporate Donated Chair Teacher., 大学院・医学研究科, 寄附講座教員 (60322806)

Co-Investigator(Kenkyū-buntansha) SAKIYAMA Yukio  Hokkaido Univ. Grad. School of Med., Corporate Donated Chair Teacher., 大学院・医学研究科, 寄附講座教員 (80133734)
Project Period (FY) 2001 – 2002
KeywordsWiskott-Aldrich syndrome / Hematopoietic stem cell transplantation / Flow cytometry / WASP / Mixed chimera
Research Abstract

The Wiskott-Aldrich syndrome (WAS) is caused by defects in the WAS protein (WASP) gene on the X-chromosome. Previously we reported that flow cytometric analysis of intracellular WASP expression (FCM-WASP) was useful for the diagnosis of WAS patients and carriers. In this study, we applied FCM-WASP to evaluate the mixed chimera (MC) status of 12 WAS patients who underwent hematopoietic stem cell transplantation (HST). After HST, donor and recipient-derived peripheral blood mononuclear cells (PBMC) could be easily distinguished by this method, as the donor cells are observed to be WASP^<bright>, while the defective recipient cells are WASP^<dim>. Furthermore, by two-color FCM-WASP, the MC status could be characterized by cell lineage. Six of 12 WAS patients were revealed to have the MC status after HST, while others had the complete chimera status. The MC was observed in every cell lineage examined. However, among PBMC, recipient cells were most commonly observed in the monocyte population. Finally, to investigate the naive/memory status of donor and recipient T cells in these patients, three-color FCM-WASP using anti-CD45RA or CD45RO was performed. It was demonstrated that, in contrast to WASP^<bright> T cells, most WASP^<dim> T cells remained naive (CD45RA^+/RO^~) more than one year after HST. No imbalance in the ratio of naive/memory T cells was observed in WAS patients before HST. We conclude that FCM-WASP is a potentially useful method for clinical follow-up of WAS patients who underwent HST. This study may also have significant implications regarding the role of WASP during hematopoietic development.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Ariga T: "T-cell linesfrom 2 patients with adenosine deaminase(ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation"Blood. 97. 2896-2899 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ariga T: "Molecular Basis for Paradoxical Carriers of Adenosine Deaminase(ADA) Deficiency That Show Extremely Low Levels of ADA Activity in Peripheral Blood Cells Without Immunodeficiency"J Immmunol. 166. 1698-1702 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ariga T: "Spontaneous In Vivo Reversion of an Inherited Mutation in the Wiskott-Aldrich Syndrome"Journal of Immunology. 166. 5245-5249 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ariga T: "Prenatal diagnosis of the Wiskott-Aldrich syndrome by PCR-based methods"Pediatrics International. 43. 716-719 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaguchi K: "Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation ; evaluation by flow cytometric analysis of intracellular WAS protein expression"Blood. 100. 1208-1214 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Otsu M: "Flow Cytometry Analysis of Adenosine Deaminase(ADA) Expression : A Simple and Reliable Tool for the Assessment of ADA-Deficient Patients Before and After Gene Therapy"Hum Gene Ther. 13. 425-432 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ariga T: "The role of common gamma chain on monocytes in vivo ; evaluation from the studies of carriers of X-linked severe combined immunodeficiency (X-SCID) and X-SCID patients who had received cord blood stem cell transplatation"British Journal of Haematology. 118. 858-863 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ariga T: "T-cell linesfrom 2 patients with adenosine deaminase(ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation"Blood. 97. 2896-2899 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ariga T: "Molecular Basis for Paradoxical Carriers of Adenosine Deaminase(ADA) Deficiency That Show Extremely Low Levels of ADA Activity in Peripheral Blood Cells Without Immunodeficiency"Journal of Immunology. 166. 1698-1702 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ariga T: "Spontaneous In Vivo Reversion of an Inherited Mutation in the Wiskott-Aldrich Syndrome"Journal of Immunology. 166. 5245-5249 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ariga T: "Prenatal diagnosis of the Wiskott-Aldrich syndrome by PCR-based methods"Pediatrics International. 43. 716-719 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaguchi K: "Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation ; evaluation by flow cytometric analysis of intracellular WAS protein expression"Blood. 100. 1208-1214 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Otsu M: "Flow Cytometry Analysis of Adenosine Deaminase(ADA) Expression : A Simple and Reliable Tool for the Assessment of ADA-Deficient Patients Before and After Gene Therapy"Hum Gene Ther. 13. 425-432 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ariga T: "The role of common gamma chain on monocytes in vivo ; evaluation from the studies of carriers of X-linked severe combined immunodeficiency (X-SCID) and X-SCID patients who had received cord blood stem cell transplatation"British Journal of Haematology. 118. 858-863 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi